Yanli Yang

2.2k total citations
87 papers, 1.5k citations indexed

About

Yanli Yang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yanli Yang has authored 87 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 23 papers in Pulmonary and Respiratory Medicine and 16 papers in Oncology. Recurrent topics in Yanli Yang's work include Tuberous Sclerosis Complex Research (9 papers), COVID-19 Clinical Research Studies (7 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers). Yanli Yang is often cited by papers focused on Tuberous Sclerosis Complex Research (9 papers), COVID-19 Clinical Research Studies (7 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers). Yanli Yang collaborates with scholars based in China, United States and India. Yanli Yang's co-authors include Kai‐Feng Xu, Xinlun Tian, Wenshuai Xu, Shao‐Ting Wang, Chao Ji, Meng Xiao, Yingchun Xu, Jing Xie, Jeanne Baker and Kari Callaway and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Yanli Yang

74 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanli Yang China 19 609 299 226 225 213 87 1.5k
Ning Zhou China 27 689 1.1× 311 1.0× 366 1.6× 161 0.7× 148 0.7× 81 1.9k
Hao Zhou China 24 522 0.9× 174 0.6× 222 1.0× 121 0.5× 154 0.7× 84 1.8k
Liang Guo China 23 543 0.9× 290 1.0× 345 1.5× 184 0.8× 160 0.8× 116 1.8k
Shanping Jiang China 23 419 0.7× 170 0.6× 238 1.1× 101 0.4× 306 1.4× 54 1.4k
Kate McArthur Australia 18 1.1k 1.8× 383 1.3× 126 0.6× 86 0.4× 157 0.7× 31 2.2k
Mahmood Yaseen Hachim United Arab Emirates 22 501 0.8× 141 0.5× 323 1.4× 137 0.6× 184 0.9× 101 1.4k
Chengshui Chen China 22 734 1.2× 109 0.4× 142 0.6× 64 0.3× 404 1.9× 92 1.5k
Zhenming Fu China 20 255 0.4× 129 0.4× 168 0.7× 88 0.4× 241 1.1× 75 1.2k
Qiu Zhang China 19 911 1.5× 279 0.9× 252 1.1× 45 0.2× 102 0.5× 79 2.2k
Zhihui Wang China 16 358 0.6× 157 0.5× 501 2.2× 206 0.9× 114 0.5× 47 1.3k

Countries citing papers authored by Yanli Yang

Since Specialization
Citations

This map shows the geographic impact of Yanli Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanli Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanli Yang more than expected).

Fields of papers citing papers by Yanli Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanli Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanli Yang. The network helps show where Yanli Yang may publish in the future.

Co-authorship network of co-authors of Yanli Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Yanli Yang. A scholar is included among the top collaborators of Yanli Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanli Yang. Yanli Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yunzhi, Han Zhang, Ling Luo, et al.. (2025). Screening and evaluation of key technologies for non-bioartificial liver care: an empirical study. Frontiers in Medicine. 11. 1459428–1459428.
2.
He, Qian, et al.. (2025). Near-infrared carbon dots: Pioneering emerging frontiers in biomedical applications. Carbon. 235. 120045–120045. 1 indexed citations
3.
Zhang, Tengyue, Xiaoxin Zhang, Wenshuai Xu, et al.. (2025). Associations of VEGF-D levels with clinical manifestations in lymphangioleiomyomatosis: a cross-sectional analysis of 631 cases. Orphanet Journal of Rare Diseases. 20(1). 255–255.
5.
Gao, Jinfang, et al.. (2025). Natural killer cells are decreased in systemic sclerosis and have diagnostic value for pulmonary arterial hypertension incorporation. Scientific Reports. 15(1). 5178–5178. 1 indexed citations
6.
Zhang, Xing, et al.. (2024). Ferroptosis related CPT1A and GDF15 gene polymorphisms are risk factors for lung adenocarcinoma: A case-control study. Gene. 933. 149002–149002. 1 indexed citations
7.
Li, Yachao, et al.. (2024). Rapid Plaque Progression in a Patient with Non-ST-Segment Elevation Acute Coronary Syndrome: A Case Report. SHILAP Revista de lepidopterología. 9(1).
9.
Wang, Guangqing, Yuxin Wang, Yanli Yang, et al.. (2023). A multifunctional cobalt–organic framework for proton conduction and selective sensing of Fe3+ ions. Dalton Transactions. 52(14). 4407–4414. 7 indexed citations
10.
Yang, Yanli, Yi Guo, Rong Wang, et al.. (2021). Effect of osimertinib in treating patients with first-generation EGFR-TKI-resistant advanced non-small cell lung cancer and prognostic analysis.. PubMed. 26(1). 51–57. 2 indexed citations
11.
Shen, Lisha, Jinsong Gao, Jun Wang, et al.. (2021). Pregnancy after the diagnosis of lymphangioleiomyomatosis (LAM). Orphanet Journal of Rare Diseases. 16(1). 133–133. 18 indexed citations
12.
13.
Yang, Yanli, et al.. (2021). Mineralization strategy on dentin bond stability: a systematic review ofin vitrostudies and meta-analysis. Journal of Adhesion Science and Technology. 36(15). 1666–1680. 6 indexed citations
14.
Xu, Wenshuai, Xinlun Tian, Yanli Yang, et al.. (2021). The etiology of diffuse cystic lung diseases: an analysis of 1010 consecutive cases in a LAM clinic. Orphanet Journal of Rare Diseases. 16(1). 273–273. 9 indexed citations
15.
Xu, Wenshuai, Lu Zhang, Yu Li, et al.. (2020). Effects of yoga on exercise capacity in patients with lymphangioleiomyomatosis: a nonrandomized controlled study. Orphanet Journal of Rare Diseases. 15(1). 72–72. 8 indexed citations
16.
Gao, Nannan, Wenshuai Xu, Jiadong Ji, et al.. (2020). Lung function and systemic inflammation associated with short-term air pollution exposure in chronic obstructive pulmonary disease patients in Beijing, China. Environmental Health. 19(1). 12–12. 92 indexed citations
17.
Hu, Siqi, Xiuxiu Wu, Wenshuai Xu, et al.. (2019). Long-term efficacy and safety of sirolimus therapy in patients with lymphangioleiomyomatosis. Orphanet Journal of Rare Diseases. 14(1). 206–206. 24 indexed citations
19.
Shen, Lisha, Wenshuai Xu, Xiuxiu Wu, et al.. (2018). Functional improvements in patients with lymphangioleiomyomatosis after sirolimus: an observational study. Orphanet Journal of Rare Diseases. 13(1). 34–34. 15 indexed citations
20.
WeiFen, Li, et al.. (2006). Preliminary investigation on parasitic nematode species of flowers and plants in Rosaceae. Xi'nan nongye xuebao. 19(5). 906–911. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026